MedTrace Logo

Educational VR Game Intervention to Enhance Hygiene Practices in Primary School Children

NCT07168759 · Status: ENROLLING_BY_INVITATION · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2160

Last updated 2025-09-11

No results posted yet for this study

Summary

The goal of this observational study is to investigate if VR game-based educational intervention can enhance primary schoolchildren's compliance with hygiene practices to prevent the transmission of SARS-CoV-2 and other upper respiratory pathogens in the community.

The main questions the study aims to answer are, after receiving the VR game-based education intervention:

* Does VR game-based educational intervention improve hygiene-practice compliance in primary schoolchildren?
* What are the bacterial loads on primary schoolchildren's hands?
* What are the rates of infections caused by SARS-CoV-2 and other respiratory viruses in primary schoolchildren?

Researchers will compare the interventional group to the control group to see if VR game-based educational intervention can enhance primary schoolchildren's hygiene practices.

Participants will

* Receive in a training programme on hygiene practices through playing VR games for two weeks, 1 hour per week.
* Do a questionnaire on hygiene knowledge before and after receiving the education programme
* Provide hand swabs and saliva samples before and after receiving the education programme

Conditions

  • Healthy Participants

Interventions

OTHER

VR game -based education program

The schoolchildren in the intervention group participate in an innovative VR game-based educational programme featuring: (1) Web-based health education on (i) SARS-CoV-2 and Influenza virus transmission, (ii) proper hand and respiratory hygiene practices and (iii) the importance of rapid screening and vaccination in the prevention of upper respiratory tract infections.

Sponsors & Collaborators

  • The Hong Kong Polytechnic University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
6 Years
Max Age
12 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-05-02
Primary Completion
2025-10-31
Completion
2025-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07168759 on ClinicalTrials.gov